Dermatology News

Thursday, December 6, 2018

By Carolyn Crist

(Reuters Health) - Patients commonly hold back information from doctors that could help in their healthcare, which could influence the care they receive or even harm them, researchers say.

Wednesday, December 5, 2018
Which type of eczema is also known as “winter itch”?
Tuesday, December 4, 2018
A recent study assessed whether a new tool for assessing the severity of actinic keratoses could determine a patient’s risk for developing squamous cell carcinoma.
Tuesday, December 4, 2018

By Reuters Staff

ZURICH (Reuters) - Novartis said on Tuesday it was taking its experimental medicine ligelizumab to late-stage trials after the drug showed signs of outperforming existing product Xolair in treating severe urticaria.

Xolair is sold by both Novartis and Roche, but has lost patent protection in Europe and the United States, leaving it exposed to rivals who are developing copies of the biological drug. None are yet on the market.

Tuesday, December 4, 2018

By Reuters Staff

(Reuters) - Medical aesthetics company Revance Therapeutics Inc said on Tuesday that its long-acting injectable drug was successful in reducing moderate-to-severe frown lines in a late-stage study.

The successful completion of the trial paves the way for Revance to submit its application for marketing approval of the drug in the first half of 2019, the company said.

Monday, December 3, 2018
An open-label pilot study investigated whether biologic treatment affected subclinical enthesopathy among patients with moderate to severe psoriasis without psoriatic arthritis.
Friday, November 30, 2018
This section will focus on more advanced techniques for improving adherence
Friday, November 30, 2018

By Marilynn Larkin

NEW YORK (Reuters Health) - Dapsone is an effective second-line treatment for chronic spontaneous urticaria (CSU) patients in whom antihistamines and other first-line therapies have failed, researchers say.

Friday, November 30, 2018
Results from a recent study suggest widespread claims regarding the safety of broad-spectrum sunscreens formulated with zinc oxide on human skin might not be supported by science. 
Friday, November 30, 2018
Which of the following is not recommended for the management of melanoma and pregnancy in the updated American Academy of Dermatology guidelines?